IGC Pharma, Inc. (IGC)
0.3019
0.00 (0.00%)
USD |
NYAM |
Apr 10, 16:00
0.30
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Profit Margin (Quarterly) : -207.4% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| electroCore, Inc. | -32.84% |
| Lantern Pharma, Inc. | -- |
| 4D Molecular Therapeutics, Inc. | 22.80% |
| NRX Pharmaceuticals, Inc. | 36.62% |
| Acurx Pharmaceuticals, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.16% |
| Return on Assets | -59.07% |
| Return on Invested Capital | -75.91% |
| Gross Profit Margin (Quarterly) | -1.71% |
| Operating Margin (Quarterly) | -840.3% |
| Return on Net Operating Assets | -74.66% |